Christopher Morabito - Net Worth and Insider Trading
Christopher Morabito Net Worth
The estimated net worth of Christopher Morabito is at least $4,807 dollars as of 2025-01-12. Christopher Morabito is the Chief Medical Officer of Fulcrum Therapeutics Inc and owns about 1,100 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $4,807. Christopher Morabito is also the Chief Medical Officer of Astria Therapeutics Inc and owns about 0 shares of Astria Therapeutics Inc (ATXS) stock worth over $0. Details can be seen in Christopher Morabito's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Morabito has not made any transactions after 2024-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Morabito
Christopher Morabito Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Morabito owns 2 companies in total, including Fulcrum Therapeutics Inc (FULC) , and Astria Therapeutics Inc (ATXS) .
Click here to see the complete history of Christopher Morabito’s form 4 insider trades.
Insider Ownership Summary of Christopher Morabito
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | Chief Medical Officer |
| ATXS | Astria Therapeutics Inc | 2024-04-01 | Chief Medical Officer |
Christopher Morabito Latest Holdings Summary
Christopher Morabito currently owns a total of 2 stocks. Among these stocks, Christopher Morabito owns 1,100 shares of Fulcrum Therapeutics Inc (FULC) as of June 28, 2021, with a value of $4,807 and a weighting of 100%. Christopher Morabito also owns 0 shares of Astria Therapeutics Inc (ATXS) as of April 1, 2024, with a value of $0 and a weighting of 0%.
Latest Holdings of Christopher Morabito
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | 1,100 | 4.37 | 4,807 |
| ATXS | Astria Therapeutics Inc | 2024-04-01 | 0 | 7.45 | 0 |
Holding Weightings of Christopher Morabito
Christopher Morabito Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Morabito has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 1,100 shares on June 28, 2021, which cost Christopher Morabito around $10,076.
According to the SEC Form 4 filings, Christopher Morabito has made a total of 2 transactions in Astria Therapeutics Inc (ATXS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Astria Therapeutics Inc is the sale of 10,000 shares on April 1, 2024, which brought Christopher Morabito around $135,900.
Insider Trading History of Christopher Morabito
- 1
Christopher Morabito Trading Performance
GuruFocus tracks the stock performance after each of Christopher Morabito's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Morabito is 206.99%. GuruFocus also compares Christopher Morabito's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Morabito within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Morabito's insider trading performs compared to the benchmark.
Performance of Christopher Morabito
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.54 | | | | | |
| Relative Return to S&P 500(%) | -17.1 | | | | | |
Christopher Morabito Ownership Network
Ownership Network List of Christopher Morabito
Ownership Network Relation of Christopher Morabito
Christopher Morabito Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Christopher Morabito is the Chief Medical Officer of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Christopher Morabito made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Christopher Morabito Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Morabito. You might contact Christopher Morabito via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
